125I-iodo-ASEM

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name125I-iodo-ASEM
Drug Alias Namenicotinic acetylcholine receptor ligand (Imperial College London/Neurobiology Research Unit/Johns Hopkins School of Medicine/Bionomics)
ClassificationRadiation-emitting products
Mechanisms of ActionNicotinic receptors modulators
TargetsNicotinic receptors
Therapy Area/IndicationsSchizophreniaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New ZealandDenmark +[5] 
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBionomics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurobiology Research Unit, Rigshospitalet, CopenhagenBionomics LtdJohns Hopkins University +[4] 
Active IndicationsN/A
Inactive IndicationsSchizophreniaAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A